InsiderSignal.AI

InsiderSignal.ai

STTK - Shattuck Labs, Inc.

Insider Purchase by Ashiya Mona (Dir)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

6 months ago, Ashiya Mona, serving as Dir at Shattuck Labs, Inc. (STTK), purchased 6,306,127 shares at $0.87 per share, for a total transaction value of $5,471,826.00. Following this transaction, Ashiya Mona now holds 1,051,021 shares of STTK.

This purchase represents a 120.00% decrease in Ashiya Mona's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, August 25, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, September 2, 2025, 8 days after the trade was made.

Shattuck Labs, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Ashiya Mona

Dir

Mona Ashiya, Ph.D. is a Director (Class I) at Shattuck Labs, Inc. (NASDAQ: STTK), appointed on August 25, 2025, as an OrbiMed Designee following the company's ~$103 million private placement financing led by OrbiMed Advisors LLC.[[1]](https://fintool.com/app/research/companies/STTK/people/mona-ashiya)[[2]](https://www.shattucklabs.com/mona-ashiya-phd/)[[6]](https://ir.shattucklabs.com/news-events/press-releases/news-details/2025/Shattuck-Labs-Announces-Closing-of-up-to-103-Million-Private-Placement-and-Appointments-to-Board-of-Directors/default.aspx) In this role, she purchased 6,306,127 shares at $0.8677 per share, valued at approximately $5.47 million, signaling strong alignment with the company's focus on immune-mediated diseases.[[1]](https://fintool.com/app/research/companies/STTK/people/mona-ashiya)[[5]](https://www.investing.com/news/insider-trading-news/ashiya-mona-buys-shattuck-labs-sttk-shares-worth-547-million-93CH-4220560)[[8]](https://www.gurufocus.com/insider/42505/mona-ashiya) Dr. Ashiya, age 56, has been a Member at OrbiMed Advisors LLC since 2010, serving in roles of increasing responsibility in biotechnology investments, and currently sits on the boards of Disc Medicine, Inc. (NASDAQ: IRON) and several private companies.[[1]](https://fintool.com/app/research/companies/STTK/people/mona-ashiya)[[2]](https://www.shattucklabs.com/mona-ashiya-phd/)[[3]](https://www.shattucklabs.com/about)[[7]](https://www.marketscreener.com/insider/MONA-ASHIYA-A0CM5I/) She holds a B.A. from the University of California, Berkeley, and a Ph.D. in Cellular, Molecular and Developmental Biology from the University of Pittsburgh, bringing deep expertise in life sciences governance and investment to her directorships.[[1]](https://fintool.com/app/research/companies/STTK/people/mona-ashiya)[[2]](https://www.shattucklabs.com/mona-ashiya-phd/)[[3]](https://www.shattucklabs.com/about)

View full insider profile →

Trade Price

$0.87

Quantity

6,306,127

Total Value

$5,471,826.00

Shares Owned

1,051,021

Trade Date

Monday, August 25, 2025

181 days ago

SEC Filing Date

Tuesday, September 2, 2025

Filed 8 days after trade

HEALTHCAREBIOTECHNOLOGY

About Shattuck Labs, Inc.

Company Overview

No company information available
View news mentioning STTK

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/173921

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime